
|Articles|September 1, 2002
Enzyme converting DHEAS to DHEA deemed viable target for anti-acne drugdevelopment
Paris - Selective inhibition of the enzyme steroid sulfatase (STS)with a topically applied nonsteroidal compound may offer a novel approachto the treatment of acne, scientists from the Novartis Research Institute,Vienna, Austria, said at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
3
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
4
Raising the Bar for HS Outcomes With Barry Resnik, MD
5










